Literature DB >> 1750507

Immunohistochemical localization of syndecan in mouse skin tumors induced by UV irradiation. Loss of expression associated with malignant transformation.

P Inki1, F Stenbäck, L Talve, M Jalkanen.   

Abstract

Immunoreactivity for syndecan, a cell surface proteoglycan, which binds extracellular matrix molecules and growth factors, was studied in hairless (hr/hr) mice exposed to UV-A and UV-B irradiation. Positive staining was observed at the surface of normal epidermal cells as well as in the dermal abortive hair follicle cysts characteristic to this mouse strain. Early reaction to UV-irradiation showing hyperplastic epidermis with slight cellular atypia showed also positive, although reduced, staining of epidermal cell surfaces. Specimens with severe dysplasia showed weak staining in the granular cell layer, whereas the basal cell layer was negative. In papillomas and keratoacanthomas, immunoreactivity for syndecan was observed in the benign hyperplastic epidermal cells as well as in the proliferating epidermal cells of the horn cysts. Malignant transformation of epithelium, expressed as the formation of early invasive and anaplastic squamous cell carcinomas, was uniformly associated with loss of syndecan staining. These results are consistent with the previous findings of reduced expression of syndecan associated with malignant transformation of cultured epithelial cells, but also suggest an important role for syndecan in the maintenance of normal tissue architecture and differentiation pattern of the skin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1750507      PMCID: PMC1886462     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  24 in total

Review 1.  Proteoglycans as modulators of growth factor activities.

Authors:  E Ruoslahti; Y Yamaguchi
Journal:  Cell       Date:  1991-03-08       Impact factor: 41.582

2.  Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation.

Authors:  A C Rapraeger; A Krufka; B B Olwin
Journal:  Science       Date:  1991-06-21       Impact factor: 47.728

3.  UVA irradiation increases the incidence of epithelial tumors in UVB-irradiated hairless mice.

Authors:  L Talve; F Stenbäck; C T Jansén
Journal:  Photodermatol Photoimmunol Photomed       Date:  1990-06       Impact factor: 3.135

4.  Cell surface proteoglycan expression correlates with epithelial-mesenchymal interaction during tooth morphogenesis.

Authors:  I Thesleff; M Jalkanen; S Vainio; M Bernfield
Journal:  Dev Biol       Date:  1988-10       Impact factor: 3.582

5.  Immunocytochemistry of cell surface heparan sulfate proteoglycan in mouse tissues. A light and electron microscopic study.

Authors:  K Hayashi; M Hayashi; M Jalkanen; J H Firestone; R L Trelstad; M Bernfield
Journal:  J Histochem Cytochem       Date:  1987-10       Impact factor: 2.479

6.  Steroid-induced epithelial-fibroblastic conversion associated with syndecan suppression in S115 mouse mammary tumor cells.

Authors:  S Leppä; P Härkönen; M Jalkanen
Journal:  Cell Regul       Date:  1991-01

7.  Life history and histopathology of ultraviolet light-induced skin tumors.

Authors:  F Stenbäck
Journal:  Natl Cancer Inst Monogr       Date:  1978-12

8.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor.

Authors:  A Yayon; M Klagsbrun; J D Esko; P Leder; D M Ornitz
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

9.  Mouse mammary epithelial cells produce basement membrane and cell surface heparan sulfate proteoglycans containing distinct core proteins.

Authors:  M Jalkanen; A Rapraeger; M Bernfield
Journal:  J Cell Biol       Date:  1988-03       Impact factor: 10.539

10.  Induced expression of syndecan in healing wounds.

Authors:  K Elenius; S Vainio; M Laato; M Salmivirta; I Thesleff; M Jalkanen
Journal:  J Cell Biol       Date:  1991-08       Impact factor: 10.539

View more
  11 in total

1.  Phosphorylation of a membrane-intercalated proteoglycan, syndecan-2, expressed in a stroma-inducing clone from a mouse Lewis lung carcinoma.

Authors:  N Itano; K Oguri; Y Nagayasu; Y Kusano; H Nakanishi; G David; M Okayama
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

2.  Activation of an enhancer on the syndecan-1 gene is restricted to fibroblast growth factor family members in mesenchymal cells.

Authors:  P Jaakkola; T Vihinen; A Määttä; M Jalkanen
Journal:  Mol Cell Biol       Date:  1997-06       Impact factor: 4.272

3.  Translational suppression of syndecan-1 expression in Ha-ras transformed mouse mammary epithelial cells.

Authors:  J Kirjavainen; S Leppä; N E Hynes; M Jalkanen
Journal:  Mol Biol Cell       Date:  1993-08       Impact factor: 4.138

Review 4.  Antithetic roles of proteoglycans in cancer.

Authors:  Elena Garusi; Silvia Rossi; Roberto Perris
Journal:  Cell Mol Life Sci       Date:  2011-10-02       Impact factor: 9.261

5.  Role of Proteoglycans in Tumor Progression.

Authors:  József Timár; András Jeney; László Kopper
Journal:  Pathol Oncol Res       Date:  1995       Impact factor: 3.201

6.  Syndecan-1 - A new piece in B-cell puzzle.

Authors:  L Kopper; A Sebestyén; M Gallai; I Kovalszky
Journal:  Pathol Oncol Res       Date:  1997-09       Impact factor: 3.201

7.  Syndecan-1 alterations during the tumorigenic progression of human colonic Caco-2 cells induced by human Ha-ras or polyoma middle T oncogenes.

Authors:  P Levy; A Munier; S Baron-Delage; Y Di Gioia; C Gespach; J Capeau; G Cherqui
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

8.  Syndecan-1 expression has prognostic significance in head and neck carcinoma.

Authors:  A Anttonen; M Kajanti; P Heikkilä; M Jalkanen; H Joensuu
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

9.  Immunohistochemical analysis of syndecan-1 in leukoplakia and oral submucous fibrosis.

Authors:  Sushant S Kamat; G S Kumar; Ajit V Koshy
Journal:  Dent Res J (Isfahan)       Date:  2013-05

10.  Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck.

Authors:  P Inki; H Joensuu; R Grénman; P Klemi; M Jalkanen
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.